Author Correction: Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade Article Swipe
Brian C. Miller
,
Debattama R. Sen
,
Rose Al Abosy
,
Kevin Bi
,
Yamini V. Virkud
,
Martin W. LaFleur
,
Kathleen B. Yates
,
Ana Lako
,
Kristen D. Felt
,
Girish S. Naik
,
Michael P. Manos
,
Evisa Gjini
,
Juhi R. Kuchroo
,
Jeffrey J. Ishizuka
,
Jenna L. Collier
,
Gabriel K. Griffin
,
Seth Maleri
,
Dawn E. Comstock
,
Sarah A. Weiss
,
Flavian D. Brown
,
Arpit Panda
,
Margaret D. Zimmer
,
Robert T. Manguso
,
F. Stephen Hodi
,
Scott J. Rodig
,
Arlene H. Sharpe
,
W. Nicholas Haining
·
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1038/s41590-019-0528-5
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1038/s41590-019-0528-5
Related Topics
Concepts
Metadata
- Type
- erratum
- Language
- en
- Landing Page
- https://doi.org/10.1038/s41590-019-0528-5
- https://www.nature.com/articles/s41590-019-0528-5.pdf
- OA Status
- bronze
- Cited By
- 26
- References
- 4
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2977605642
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2977605642Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1038/s41590-019-0528-5Digital Object Identifier
- Title
-
Author Correction: Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockadeWork title
- Type
-
erratumOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-10-03Full publication date if available
- Authors
-
Brian C. Miller, Debattama R. Sen, Rose Al Abosy, Kevin Bi, Yamini V. Virkud, Martin W. LaFleur, Kathleen B. Yates, Ana Lako, Kristen D. Felt, Girish S. Naik, Michael P. Manos, Evisa Gjini, Juhi R. Kuchroo, Jeffrey J. Ishizuka, Jenna L. Collier, Gabriel K. Griffin, Seth Maleri, Dawn E. Comstock, Sarah A. Weiss, Flavian D. Brown, Arpit Panda, Margaret D. Zimmer, Robert T. Manguso, F. Stephen Hodi, Scott J. Rodig, Arlene H. Sharpe, W. Nicholas HainingList of authors in order
- Landing page
-
https://doi.org/10.1038/s41590-019-0528-5Publisher landing page
- PDF URL
-
https://www.nature.com/articles/s41590-019-0528-5.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://www.nature.com/articles/s41590-019-0528-5.pdfDirect OA link when available
- Concepts
-
Blockade, CD8, Cytotoxic T cell, Cancer research, Cell biology, Biology, Immunology, Genetics, Antigen, Receptor, In vitroTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
26Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 3, 2024: 8, 2023: 4, 2022: 5, 2021: 6Per-year citation counts (last 5 years)
- References (count)
-
4Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2977605642 |
|---|---|
| doi | https://doi.org/10.1038/s41590-019-0528-5 |
| ids.doi | https://doi.org/10.1038/s41590-019-0528-5 |
| ids.mag | 2977605642 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/31582823 |
| ids.openalex | https://openalex.org/W2977605642 |
| fwci | 2.29262466 |
| type | erratum |
| title | Author Correction: Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade |
| biblio.issue | 11 |
| biblio.volume | 20 |
| biblio.last_page | 1556 |
| biblio.first_page | 1556 |
| topics[0].id | https://openalex.org/T12626 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9431999921798706 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2738 |
| topics[0].subfield.display_name | Psychiatry and Mental health |
| topics[0].display_name | Cancer, Stress, Anesthesia, and Immune Response |
| topics[1].id | https://openalex.org/T10158 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9222000241279602 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Cancer Immunotherapy and Biomarkers |
| topics[2].id | https://openalex.org/T11313 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9100000262260437 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | Immune cells in cancer |
| is_xpac | False |
| apc_list.value | 9750 |
| apc_list.currency | EUR |
| apc_list.value_usd | 11690 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2778468042 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7736475467681885 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q273976 |
| concepts[0].display_name | Blockade |
| concepts[1].id | https://openalex.org/C167672396 |
| concepts[1].level | 3 |
| concepts[1].score | 0.5092079043388367 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q417800 |
| concepts[1].display_name | CD8 |
| concepts[2].id | https://openalex.org/C154317977 |
| concepts[2].level | 3 |
| concepts[2].score | 0.4454346001148224 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q376266 |
| concepts[2].display_name | Cytotoxic T cell |
| concepts[3].id | https://openalex.org/C502942594 |
| concepts[3].level | 1 |
| concepts[3].score | 0.43265578150749207 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[3].display_name | Cancer research |
| concepts[4].id | https://openalex.org/C95444343 |
| concepts[4].level | 1 |
| concepts[4].score | 0.4191310405731201 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[4].display_name | Cell biology |
| concepts[5].id | https://openalex.org/C86803240 |
| concepts[5].level | 0 |
| concepts[5].score | 0.4121287763118744 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[5].display_name | Biology |
| concepts[6].id | https://openalex.org/C203014093 |
| concepts[6].level | 1 |
| concepts[6].score | 0.3927313983440399 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[6].display_name | Immunology |
| concepts[7].id | https://openalex.org/C54355233 |
| concepts[7].level | 1 |
| concepts[7].score | 0.20311754941940308 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[7].display_name | Genetics |
| concepts[8].id | https://openalex.org/C147483822 |
| concepts[8].level | 2 |
| concepts[8].score | 0.12192800641059875 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q103537 |
| concepts[8].display_name | Antigen |
| concepts[9].id | https://openalex.org/C170493617 |
| concepts[9].level | 2 |
| concepts[9].score | 0.10983017086982727 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[9].display_name | Receptor |
| concepts[10].id | https://openalex.org/C202751555 |
| concepts[10].level | 2 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[10].display_name | In vitro |
| keywords[0].id | https://openalex.org/keywords/blockade |
| keywords[0].score | 0.7736475467681885 |
| keywords[0].display_name | Blockade |
| keywords[1].id | https://openalex.org/keywords/cd8 |
| keywords[1].score | 0.5092079043388367 |
| keywords[1].display_name | CD8 |
| keywords[2].id | https://openalex.org/keywords/cytotoxic-t-cell |
| keywords[2].score | 0.4454346001148224 |
| keywords[2].display_name | Cytotoxic T cell |
| keywords[3].id | https://openalex.org/keywords/cancer-research |
| keywords[3].score | 0.43265578150749207 |
| keywords[3].display_name | Cancer research |
| keywords[4].id | https://openalex.org/keywords/cell-biology |
| keywords[4].score | 0.4191310405731201 |
| keywords[4].display_name | Cell biology |
| keywords[5].id | https://openalex.org/keywords/biology |
| keywords[5].score | 0.4121287763118744 |
| keywords[5].display_name | Biology |
| keywords[6].id | https://openalex.org/keywords/immunology |
| keywords[6].score | 0.3927313983440399 |
| keywords[6].display_name | Immunology |
| keywords[7].id | https://openalex.org/keywords/genetics |
| keywords[7].score | 0.20311754941940308 |
| keywords[7].display_name | Genetics |
| keywords[8].id | https://openalex.org/keywords/antigen |
| keywords[8].score | 0.12192800641059875 |
| keywords[8].display_name | Antigen |
| keywords[9].id | https://openalex.org/keywords/receptor |
| keywords[9].score | 0.10983017086982727 |
| keywords[9].display_name | Receptor |
| language | en |
| locations[0].id | doi:10.1038/s41590-019-0528-5 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S41063453 |
| locations[0].source.issn | 1529-2908, 1529-2916 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1529-2908 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Nature Immunology |
| locations[0].source.host_organization | https://openalex.org/P4310319908 |
| locations[0].source.host_organization_name | Nature Portfolio |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| locations[0].license | |
| locations[0].pdf_url | https://www.nature.com/articles/s41590-019-0528-5.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Nature Immunology |
| locations[0].landing_page_url | https://doi.org/10.1038/s41590-019-0528-5 |
| locations[1].id | pmid:31582823 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Nature immunology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/31582823 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:7461603 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Nat Immunol |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/7461603 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5036566851 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5931-4184 |
| authorships[0].author.display_name | Brian C. Miller |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[0].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[0].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Brian C. Miller |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[1].author.id | https://openalex.org/A5054012911 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-0947-8284 |
| authorships[1].author.display_name | Debattama R. Sen |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[1].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[1].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Debattama R. Sen |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[2].author.id | https://openalex.org/A5044532868 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-5400-1306 |
| authorships[2].author.display_name | Rose Al Abosy |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[2].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[2].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[2].institutions[0].type | facility |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Rose Al Abosy |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[3].author.id | https://openalex.org/A5067450389 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-6794-1804 |
| authorships[3].author.display_name | Kevin Bi |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[3].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[3].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[3].institutions[0].type | facility |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Kevin Bi |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[4].author.id | https://openalex.org/A5071234496 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-7328-7215 |
| authorships[4].author.display_name | Yamini V. Virkud |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210087915 |
| authorships[4].affiliations[0].raw_affiliation_string | Division of Pediatric Allergy and Immunology, Massachusetts General Hospital, Boston, MA, USA |
| authorships[4].institutions[0].id | https://openalex.org/I4210087915 |
| authorships[4].institutions[0].ror | https://ror.org/002pd6e78 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210087915, https://openalex.org/I48633490 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Massachusetts General Hospital |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Yamini V. Virkud |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Division of Pediatric Allergy and Immunology, Massachusetts General Hospital, Boston, MA, USA |
| authorships[5].author.id | https://openalex.org/A5066544742 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-5017-774X |
| authorships[5].author.display_name | Martin W. LaFleur |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[5].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[5].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[5].institutions[0].type | facility |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Martin W. LaFleur |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[6].author.id | https://openalex.org/A5069003214 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-7383-5573 |
| authorships[6].author.display_name | Kathleen B. Yates |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[6].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[6].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[6].institutions[0].type | facility |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Kathleen B. Yates |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[7].author.id | https://openalex.org/A5051793744 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-2931-6212 |
| authorships[7].author.display_name | Ana Lako |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[7].affiliations[0].raw_affiliation_string | Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[7].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[7].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[7].institutions[0].type | facility |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Ana Lako |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[8].author.id | https://openalex.org/A5028264464 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-7063-8374 |
| authorships[8].author.display_name | Kristen D. Felt |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[8].affiliations[0].raw_affiliation_string | Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[8].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[8].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[8].institutions[0].type | facility |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Kristen Felt |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[9].author.id | https://openalex.org/A5005410041 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-2832-0001 |
| authorships[9].author.display_name | Girish S. Naik |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[9].affiliations[0].raw_affiliation_string | Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[9].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[9].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[9].institutions[0].type | facility |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Girish S. Naik |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[10].author.id | https://openalex.org/A5070590609 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-0841-207X |
| authorships[10].author.display_name | Michael P. Manos |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[10].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[10].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[10].institutions[0].type | facility |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Michael Manos |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[11].author.id | https://openalex.org/A5005477709 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-6951-9279 |
| authorships[11].author.display_name | Evisa Gjini |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[11].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[11].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[11].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[11].institutions[0].type | facility |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Evisa Gjini |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[12].author.id | https://openalex.org/A5063665543 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-9033-3420 |
| authorships[12].author.display_name | Juhi R. Kuchroo |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I1283280774, https://openalex.org/I136199984 |
| authorships[12].affiliations[0].raw_affiliation_string | Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA |
| authorships[12].institutions[0].id | https://openalex.org/I1283280774 |
| authorships[12].institutions[0].ror | https://ror.org/04b6nzv94 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I1283280774, https://openalex.org/I48633490 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | Brigham and Women's Hospital |
| authorships[12].institutions[1].id | https://openalex.org/I136199984 |
| authorships[12].institutions[1].ror | https://ror.org/03vek6s52 |
| authorships[12].institutions[1].type | education |
| authorships[12].institutions[1].lineage | https://openalex.org/I136199984 |
| authorships[12].institutions[1].country_code | US |
| authorships[12].institutions[1].display_name | Harvard University |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Juhi R. Kuchroo |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA |
| authorships[13].author.id | https://openalex.org/A5067516923 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-4271-7312 |
| authorships[13].author.display_name | Jeffrey J. Ishizuka |
| authorships[13].countries | US |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[13].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[13].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[13].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[13].institutions[0].type | facility |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[13].institutions[0].country_code | US |
| authorships[13].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Jeffrey J. Ishizuka |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[14].author.id | https://openalex.org/A5051491416 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-4071-4986 |
| authorships[14].author.display_name | Jenna L. Collier |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[14].affiliations[0].raw_affiliation_string | Broad Institute of MIT and Harvard, Cambridge, MA, USA |
| authorships[14].institutions[0].id | https://openalex.org/I107606265 |
| authorships[14].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[14].institutions[0].type | nonprofit |
| authorships[14].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | Broad Institute |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Jenna L. Collier |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Broad Institute of MIT and Harvard, Cambridge, MA, USA |
| authorships[15].author.id | https://openalex.org/A5070357190 |
| authorships[15].author.orcid | https://orcid.org/0009-0006-0185-1239 |
| authorships[15].author.display_name | Gabriel K. Griffin |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[15].affiliations[0].raw_affiliation_string | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[15].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[15].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[15].institutions[0].type | facility |
| authorships[15].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Gabriel K. Griffin |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[16].author.id | https://openalex.org/A5004121284 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Seth Maleri |
| authorships[16].countries | US |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I1283280774, https://openalex.org/I136199984 |
| authorships[16].affiliations[0].raw_affiliation_string | Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA |
| authorships[16].institutions[0].id | https://openalex.org/I1283280774 |
| authorships[16].institutions[0].ror | https://ror.org/04b6nzv94 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I1283280774, https://openalex.org/I48633490 |
| authorships[16].institutions[0].country_code | US |
| authorships[16].institutions[0].display_name | Brigham and Women's Hospital |
| authorships[16].institutions[1].id | https://openalex.org/I136199984 |
| authorships[16].institutions[1].ror | https://ror.org/03vek6s52 |
| authorships[16].institutions[1].type | education |
| authorships[16].institutions[1].lineage | https://openalex.org/I136199984 |
| authorships[16].institutions[1].country_code | US |
| authorships[16].institutions[1].display_name | Harvard University |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Seth Maleri |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA |
| authorships[17].author.id | https://openalex.org/A5041669734 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-3718-8372 |
| authorships[17].author.display_name | Dawn E. Comstock |
| authorships[17].countries | US |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[17].affiliations[0].raw_affiliation_string | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[17].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[17].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[17].institutions[0].type | facility |
| authorships[17].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[17].institutions[0].country_code | US |
| authorships[17].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Dawn E. Comstock |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[18].author.id | https://openalex.org/A5015198759 |
| authorships[18].author.orcid | |
| authorships[18].author.display_name | Sarah A. Weiss |
| authorships[18].countries | US |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[18].affiliations[0].raw_affiliation_string | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[18].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[18].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[18].institutions[0].type | facility |
| authorships[18].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[18].institutions[0].country_code | US |
| authorships[18].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Sarah A. Weiss |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[19].author.id | https://openalex.org/A5041863892 |
| authorships[19].author.orcid | |
| authorships[19].author.display_name | Flavian D. Brown |
| authorships[19].countries | US |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[19].affiliations[0].raw_affiliation_string | Broad Institute of MIT and Harvard, Cambridge, MA, USA |
| authorships[19].institutions[0].id | https://openalex.org/I107606265 |
| authorships[19].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[19].institutions[0].type | nonprofit |
| authorships[19].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[19].institutions[0].country_code | US |
| authorships[19].institutions[0].display_name | Broad Institute |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Flavian D. Brown |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Broad Institute of MIT and Harvard, Cambridge, MA, USA |
| authorships[20].author.id | https://openalex.org/A5023103707 |
| authorships[20].author.orcid | |
| authorships[20].author.display_name | Arpit Panda |
| authorships[20].countries | US |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[20].affiliations[0].raw_affiliation_string | Broad Institute of MIT and Harvard, Cambridge, MA, USA |
| authorships[20].institutions[0].id | https://openalex.org/I107606265 |
| authorships[20].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[20].institutions[0].type | nonprofit |
| authorships[20].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[20].institutions[0].country_code | US |
| authorships[20].institutions[0].display_name | Broad Institute |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Arpit Panda |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Broad Institute of MIT and Harvard, Cambridge, MA, USA |
| authorships[21].author.id | https://openalex.org/A5049020272 |
| authorships[21].author.orcid | https://orcid.org/0000-0002-3317-6569 |
| authorships[21].author.display_name | Margaret D. Zimmer |
| authorships[21].countries | US |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[21].affiliations[0].raw_affiliation_string | Broad Institute of MIT and Harvard, Cambridge, MA, USA |
| authorships[21].institutions[0].id | https://openalex.org/I107606265 |
| authorships[21].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[21].institutions[0].type | nonprofit |
| authorships[21].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[21].institutions[0].country_code | US |
| authorships[21].institutions[0].display_name | Broad Institute |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Margaret D. Zimmer |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | Broad Institute of MIT and Harvard, Cambridge, MA, USA |
| authorships[22].author.id | https://openalex.org/A5082908624 |
| authorships[22].author.orcid | https://orcid.org/0000-0003-1336-413X |
| authorships[22].author.display_name | Robert T. Manguso |
| authorships[22].countries | US |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[22].affiliations[0].raw_affiliation_string | Broad Institute of MIT and Harvard, Cambridge, MA, USA |
| authorships[22].institutions[0].id | https://openalex.org/I107606265 |
| authorships[22].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[22].institutions[0].type | nonprofit |
| authorships[22].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[22].institutions[0].country_code | US |
| authorships[22].institutions[0].display_name | Broad Institute |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Robert T. Manguso |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | Broad Institute of MIT and Harvard, Cambridge, MA, USA |
| authorships[23].author.id | https://openalex.org/A5084967339 |
| authorships[23].author.orcid | https://orcid.org/0000-0001-6825-091X |
| authorships[23].author.display_name | F. Stephen Hodi |
| authorships[23].countries | US |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[23].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[23].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[23].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[23].institutions[0].type | facility |
| authorships[23].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[23].institutions[0].country_code | US |
| authorships[23].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | F. Stephen Hodi |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[24].author.id | https://openalex.org/A5058975989 |
| authorships[24].author.orcid | https://orcid.org/0000-0003-1761-9769 |
| authorships[24].author.display_name | Scott J. Rodig |
| authorships[24].countries | US |
| authorships[24].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[24].affiliations[0].raw_affiliation_string | Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[24].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[24].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[24].institutions[0].type | facility |
| authorships[24].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[24].institutions[0].country_code | US |
| authorships[24].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Scott J. Rodig |
| authorships[24].is_corresponding | False |
| authorships[24].raw_affiliation_strings | Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| authorships[25].author.id | https://openalex.org/A5044052948 |
| authorships[25].author.orcid | https://orcid.org/0000-0002-9736-2109 |
| authorships[25].author.display_name | Arlene H. Sharpe |
| authorships[25].countries | US |
| authorships[25].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[25].affiliations[0].raw_affiliation_string | Broad Institute of MIT and Harvard, Cambridge, MA, USA |
| authorships[25].institutions[0].id | https://openalex.org/I107606265 |
| authorships[25].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[25].institutions[0].type | nonprofit |
| authorships[25].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[25].institutions[0].country_code | US |
| authorships[25].institutions[0].display_name | Broad Institute |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Arlene H. Sharpe |
| authorships[25].is_corresponding | False |
| authorships[25].raw_affiliation_strings | Broad Institute of MIT and Harvard, Cambridge, MA, USA |
| authorships[26].author.id | https://openalex.org/A5043992139 |
| authorships[26].author.orcid | https://orcid.org/0000-0001-7871-3762 |
| authorships[26].author.display_name | W. Nicholas Haining |
| authorships[26].countries | US |
| authorships[26].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[26].affiliations[0].raw_affiliation_string | Broad Institute of MIT and Harvard, Cambridge, MA, USA |
| authorships[26].institutions[0].id | https://openalex.org/I107606265 |
| authorships[26].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[26].institutions[0].type | nonprofit |
| authorships[26].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[26].institutions[0].country_code | US |
| authorships[26].institutions[0].display_name | Broad Institute |
| authorships[26].author_position | last |
| authorships[26].raw_author_name | W. Nicholas Haining |
| authorships[26].is_corresponding | False |
| authorships[26].raw_affiliation_strings | Broad Institute of MIT and Harvard, Cambridge, MA, USA |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.nature.com/articles/s41590-019-0528-5.pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2019-10-10T00:00:00 |
| display_name | Author Correction: Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12626 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9431999921798706 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2738 |
| primary_topic.subfield.display_name | Psychiatry and Mental health |
| primary_topic.display_name | Cancer, Stress, Anesthesia, and Immune Response |
| related_works | https://openalex.org/W3087470930, https://openalex.org/W1937493075, https://openalex.org/W2414729062, https://openalex.org/W1497833379, https://openalex.org/W2402467954, https://openalex.org/W4313313459, https://openalex.org/W2040631670, https://openalex.org/W2049624095, https://openalex.org/W1964266791, https://openalex.org/W2035137452 |
| cited_by_count | 26 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 3 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 8 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 4 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 5 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 6 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1038/s41590-019-0528-5 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S41063453 |
| best_oa_location.source.issn | 1529-2908, 1529-2916 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1529-2908 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Nature Immunology |
| best_oa_location.source.host_organization | https://openalex.org/P4310319908 |
| best_oa_location.source.host_organization_name | Nature Portfolio |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://www.nature.com/articles/s41590-019-0528-5.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Nature Immunology |
| best_oa_location.landing_page_url | https://doi.org/10.1038/s41590-019-0528-5 |
| primary_location.id | doi:10.1038/s41590-019-0528-5 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S41063453 |
| primary_location.source.issn | 1529-2908, 1529-2916 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1529-2908 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Nature Immunology |
| primary_location.source.host_organization | https://openalex.org/P4310319908 |
| primary_location.source.host_organization_name | Nature Portfolio |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| primary_location.license | |
| primary_location.pdf_url | https://www.nature.com/articles/s41590-019-0528-5.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Nature Immunology |
| primary_location.landing_page_url | https://doi.org/10.1038/s41590-019-0528-5 |
| publication_date | 2019-10-03 |
| publication_year | 2019 |
| referenced_works | https://openalex.org/W2944872709, https://openalex.org/W2980156560, https://openalex.org/W2976744773, https://openalex.org/W2979295332 |
| referenced_works_count | 4 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 97 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 27 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.41999998688697815 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.84574663 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |